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Abstract. Synaptogyrin (p29) is a synaptic vesicle pro- 
tein that is uniformly distributed in the nervous system 
(Baumert et al., 1990). We have cloned and sequenced 
the cDNA encoding synaptogyrin, and the sequence 
predicts a protein with a molecular mass of 25,900 D 
with four membrane-spanning domains. The topology 
of the protein was confirmed by limited proteolysis us- 
ing domain-specific antibodies. Database searches re- 
vealed several cDNA sequences coding polypeptides 
with sequence identities ranging from 32 to 46%, sug- 
gesting that synaptogyrin is a member of a multigene 
family. When the synaptogyrin cDNA is expressed in 
COS cells, the generated protein is indistinguishable 
from native synaptogyrin. To study intracellular sort- 
ing, synaptogyrin was expressed in CHO cells that re- 
vealed a punctate staining that was very similar to that 
of synaptophysin and endogenously expressed ceUubre- 
vin. Significant overlap with transferrin staining was 
also observed, suggesting that synaptogyrin is targeted 
to a recycling compartment involved in membrane traf- 
fic to and from the plasma membrane. 
~ 
YNAPTIC vesicles  are  storage  organelles for neuro- 
transmitters in nerve terminals. Upon arrival of an 
K.3  action potential, voltage-gated Ca2+-channels open, 
and with a delay that may be as short as 200 I~s, synaptic 
vesicles fuse with the presynaptic plasma membrane, dis- 
charging their transmitter content into the synaptic cleft. 
The membrane is then retrieved and used to regenerate 
exocytosis-competent synaptic vesicles, possibly involving 
passage through clathrin-coated vesicles (Maycox et al., 
1992) and early endosomes as intermediate steps (for re- 
view see Jahn  and  Siidhof, 1994; Bennett and  Scheller, 
1994). 
Although neuronal exocytosis is highly specialized, many 
properties of the synaptic vesicle pathway resemble that of 
constitutive membrane  traffic to  and  from  the  plasma 
membrane, which is an integral component of every eu- 
karyotic cell (De Camilli and Jahn, 1990; Kelly, 1993). In 
fact, recent developments have shown that these similari- 
ties extend to the molecular steps underlying intracellular 
membrane fusion (Bennett and Scheller, 1994). It is pres- 
ently understood that  membrane fusion is  mediated by 
specific protein famiIies that are conserved from relatively 
simple eukaryotic cells such as yeast to highly differenti- 
ated cells such as neurons (Ferro-Novick and Jahn, 1994). 
To achieve a comprehensive understanding of the mo- 
lecular elements involved in membrane traffic, it is essen- 
tial to characterize the protein constituents of intracellular 
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trafficking organelles. These proteins not only define the 
identity of a trafficking organelle but also serve as the ba- 
sis for essentially all functions an organelle must perform. 
Ideally, it should be possible to achieve a complete molec- 
ular description of a  prototype trafficking organelle that 
can then be used as a model for vesicles functioning in dif- 
ferent pathways of other cells. In the past few years, syn- 
aptic vesicles have served as such a prototype organelle. 
Due to their small size, the number of protein molecules 
an individual vesicle can carry is limited (see  Jahn and 
Stidhof, 1993 for further discussion). The protein composi- 
tion of purified vesicles appears to be rather simple, con- 
taining only a few major polypeptides. Furthermore, syn- 
aptic vesicles can easily be purified in large quantities. For 
these reasons, their protein composition is better under- 
stood than that of any other trafficking organelle (for re- 
view see Jahn and  Stidhof, 1994; Bennett and  Scheller, 
1994;  Siidhof, 1995).  In  many cases,  proteins  identified 
first in synaptic vesicles were later found to be representa- 
tives of larger protein  families that function in all cells 
(Zhong et al., 1992; McMahon et al., 1993; Leube, 1994; Li 
et al., 1995). 
While the proteins responsible for neurotransmitter up- 
take can  be  studied easily using functional approaches, 
structural characterization of vesicular trafficking proteins 
has  been  an  essential  prerequisite  to  understand  their 
function. Almost all of the vesicular trafficking proteins 
were identified before their roles were understood. Pres- 
ently, well-founded working models have been established 
for most of their functions. Thus, the synaptobrevins are 
essential components of a presynaptic fusion complex that 
mediates exocytosis in concert with soluble protein factors 
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date for the Ca2÷-receptor that is responsible for the fast 
exocytotic response upon Ca2+-influx (Brose et al.,  1992; 
Geppert et al.,  1994a),  and rab3A  is  involved in vesicle 
docking (Lledo et al.,  1993;  Geppert et al.,  1994b).  The 
synapsins are important regulators that facilitate synaptic 
vesicle membrane  traffic but  are  not  required for basic 
trafficking functions (Pieribone et al.,  1995; Rosahl et al., 
1995). Synaptophysin, the first of the vesicle proteins char- 
acterized in molecular terms, has been implicated recently 
in regulating the availability of synaptobrevin to enter the 
presynaptic fusion complex (Calakos and Scheller, 1994; 
Edelmann et al., 1995; Washbourne et al., 1995). 
For these reasons, it is very important to complete the 
molecular characterization of synaptic vesicle constituents. 
Previously, we have identified a membrane protein of syn- 
aptic vesicles with an apparent molecular mass of 29,000 
D, referred to as p29 (Baumert et al.,  1990).  P29 is highly 
expressed in neurons and neuroendocrine cells where it is 
colocalized with synaptophysin on small synaptic vesicles 
and synaptic-like microvesicles, respectively. Like synap- 
tophysin, p29 is phosphorylated on tyrosine residues. Fur- 
thermore,  some  antibodies  (including  two  monoclonal 
IgM  antibodies)  raised  against  p29  showed  weak cross- 
reactivity with  synaptophysin, indicating  some  structural 
similarity. In contrast to synaptophysin, no evidence for 
N-linked glycosylation was found (Baumert et al., 1990). 
Here we report the molecular characterization of p29, now 
renamed synaptogyrin (from Greek ~opoq = circle, as a ref- 
erence to the circular structure of synaptic vesicles). Fur- 
thermore, we have characterized its topology and sorting 
upon expression in nonneuronal cells. The protein has an 
overall structure similar to that of synaptophysin although 
the sequences are only distantly related. A search of data- 
bases containing human cDNA sequences revealed the ex- 
istence of polypeptides homologous to synaptogyrin, sug- 
gesting that synaptogyrin is the first characterized member 
of a novel protein family. 
Materials and Methods 
Purification and Microsequencing of Synaptogyrin 
Synaptic vesicles were purified as previously described (Nagy et al., 1976; 
Huttner et al., 1983; Hell and Jahn, 1994), using controlled pore glass bead 
chromatography as the last purification step. Peripheral membrane pro- 
teins were removed by incubation  in 0.1 M Na2HCO3 at pH 11 for 15 min 
on ice. The proteins were separated by two-dimensional gel electrophore- 
sis according to Mcfarlane (1989). The protein spot corresponding to p29 
was identified by immunoblotting using a polyclonal antibody (Baumert 
et al., 1990)  and excised from electrophoresis gels. For peptide microse- 
quencing, protein spots from several gels were pooled and submitted to 
the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale 
University (New Haven, CT). The protein in the Coomassie stained gel 
pieces were digested with trypsin in situ, and the resulting tryptic frag- 
ments eluted from the gel matrix. The tryptic fragments were purified us- 
ing reverse phase HPLC and subjected to laser desorption mass spectrom- 
etry  before  peptide  microsequencing (Williams and  Stone,  1995).  The 
peptide  microsequences obtained  were  checked  against various nucle- 
otide and protein databases for potential matches, and none were found. 
Two  peptide  sequences (AGGAFDPYTLVR  and  DNPLNEGTDAA) 
were used to construct degenerate oligonucleotides for PCR. 
cDNA Cloning and Sequencing of Synaptogyrin 
The oligonucleotides were used to amplify a 400-bp eDNA sequence by 
PCR from rat brain cDNA. This sequence served as a probe for screening 
a  rat  brain kZAP cDNA library purchased from Stratagene  (La Jolla, 
CA). Four different clones were isolated, mapped and sequenced by sub- 
cloning the fragments into a  M13 vector and sequencing the vector ac- 
cording to standard procedures using an automated DNA sequencer from 
Applied Biosystems, Inc. (Foster City, CA). All the clones overlapped in 
sequence, and the two longest clones contained an open reading frame 
that encodes a 234-amino acid protein. The coding region and most of the 
5' and 3' untranslated regions were sequenced on both strands. A 940-bp 
EcoRI/Xbal  insert containing the coding sequence and 20 bp of 5'  un- 
translated sequence and 200 bp of 3' untranslated sequence was subcloned 
into a pCMV5 vector (Andersson et al., 1989)  for transfection of fibro- 
blasts. 
Cell Culture and Expression of Synaptogyrin in CHO 
and COS Cells 
Both the CHO  and COS-7 cell lines were  grown in DMET containing 
10%  heat-inactivated fetal calf serum, 10 mM Hepes, pH 7.4,  100 U/ml 
penicillin, 100 ixg/ml streptomycin and 2 mM L-glutamine at 37°C in 10% 
CO2.  A  cell line stably expressing synaptophysin (p38CHO; Johnston et 
al., 1989b) was grown in DMET supplemented with 10% heat-inactivated 
fetal calf serum, 20 mM Hepes, pH 7.4, 34 g/ml proline, 100 U/ml penicil- 
lin, 100 p.g/ml streptomycin, 2 mM L-glutamine and maintained under con- 
stant selection with 700 txg/ml active G418 (GIBCO BRL, Gaithersburg, 
MD) at 37°C in 10% CO2. Only during transfection experiments was me- 
dia devoid of fetal calf serum, penicillin, streptomycin and G418 used. 
COS-7 cells were transfected with the pCMV5-construct using the cal- 
cium phosphate precipitation  method (Chen and Okayama, 1987).  The 
cells were harvested using a rubber policeman and solubilized for 30 rain 
on ice in 2% Triton X-100 in 20 mM Hepes, pH 7.4. The Triton X-100 in- 
soluble material was pelleted at 900 g for 20 rain. Aliquots of the pellet 
and the supernatant obtained from synaptogyrin-transfected COS  cells 
and from untransfected control COS cells were analyzed by immunoblot- 
ting for synaptogyrin. 
CHO cells were transfected using transfectamine liposomes (GIBCO 
BRL,  Gaithersburg, MD).  8  txg DNA  (see  above)  and 32  txl of trans- 
fectamine were added to 200 Ixl media lacking serum, penicillin, strepto- 
mycin, and G418.  After incubation for at least 20 rain the transfection 
mixture was added to the cells. The cells were incubated for 3--4 h before 
the mixture was replaced with normal media. 
Immunocytochemistry 
Cells were passed onto polyornithine-coated coverslips in 6-weU plates the 
day after transfection, and allowed to grow for another 24-48 h. For trans- 
ferrin labeling, the cells were allowed to internalize exogenously added 
iron-saturated human transferrin (100  ixM final concentration) through 
receptor-mediated endocytosis in serum-free media added 25 rain before 
fixing. For fixation, all cells were rinsed with PBS supplemented with 0.9 
mM CaC12 and 0.5 mM MgC12 (PBS*) and fixed for 40 min in 2.5% para- 
formaldehyde in PBS*. All subsequent blocking, incubation and wash- 
ing steps were performed using a blocking solution of 1% bovine serum albu- 
min and  0.03%  saponin in  PBS*.  The cells were  examined through a 
Zeiss-Axiophot epifluorescence microscope (Carl Zeiss Inc., Thornwood, 
NY) and photographed using Kodak Gold 100 ASA color print film. Con- 
focal images were collected using a MRC-600 system attached to a Zeiss 
Axiovert compound microscope. The program ENHANCE was used on 
images as they were collected. For photo reproduction, image files were 
transferred to a Macintosh IIfx computer and arranged and annotated us- 
ing Adobe  Photoshop version 3.0 (Adobe Systems, Inc., Mountainview, 
CA) as software. 
Antibodies 
Rabbit IgG specific for human transferrin was purchased from Accurate 
Chemical &  Scientific Corp. (Westbury, NY). The secondary antibodies 
used in the immunofluorescence experiments with CHO cells were anti- 
mouse  FITC  and  Texas  Red-conjugated  goat  antibodies,  anti-rabbit 
dichlorotriazinylamino fluorescein (DTAF) 1 and indocarbocyanine (CY3) 
conjugated  goat  antibodies  purchased  from  Jackson  Immunoresearch 
Laboratories (West Grove, PA). 
1. Abbreviations used in this paper: DTAF, dichlorotriazinylamino fluo- 
rescein; ECL, enhanced chemiluminescence. 
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rum directed against synaptogyrin (p29)  (Baumert et al., 1990),  rabbit 
serum directed against synaptophysin (Jahn et al., 1985), monoclonal anti- 
body directed against the NH2 terminus of synaptotagmin (clone C1 604.4, 
Chapman and Jahn, 1994), rabbit serum directed against the first intrave- 
sicular loop of synaptophysin (p38-2;  Johnston et aL, 1989a),  and rabbit 
serum directed against cellubrevin (McMahon et al.,  1993). For synapto- 
gyrin, we generated new polyclonal and monoclonal antibodies. Rabbit 
sera were raised against two synthetic peptides immobilized to keyhole 
limpet hemocyanine using standard procedures (Schneider et al., 1983). 
One of the peptides corresponded to the first predicted intravesicular loop 
(CIYNRNPNACSYG, residues no. 59-71), and the second corresponded 
to  the cytoplasmic tail  region  (CQDYMDPSQDSSMPY,  residues  no. 
182-196).  These antibodies were affinity purified using peptide immobi- 
lized to thiopropyl Sepharose (Pharmacia Biotech AB, Uppsala, Sweden) 
according to the manufacturer's protocol. A third rabbit serum was raised 
using cytoplasmic tail region of synaptogyrin as antigen. For this purpose, 
residues no. 169-234  were expressed in bacteria as a GST-fusion protein 
and purified on GST-Sepharose according to the protocol provided by 
Pharmacia Biotech AB. Finally, a new IgG2-secreting mouse hybridoma 
line  was  established (clone  C1  80.1)  according to  standard  procedures 
(Krhler and Milstein, 1975; Jahn et al.,  1985) using the same fusion pro- 
tein as antigen. 
Miscellaneous Procedures 
Nerve  terminals  were  isolated  according  to  McMahon  and  NichoUs 
(1991).  Pronase digestion of synaptic vesicles was performed as described 
by  Johnston  et  al.  (1989a).  SDS-PAGE  was  performed  according  to 
Laemmli (1970)  using a Bio-Rad Protean II minigel apparatus. Immuno- 
blotting was carried out as described in Jahn et al.  (1985)  with the en- 
hanced chemiluminescence (ECL) detection kit (Amersham Life Science, 
Buckinghamshire,  England)  or  *~I-conjugated  protein  A  (Amersham 
Chemical Co., Arlington Heights, IL) as detection methods. The images in 
Figs. 3 and 5 were generated by scanning the autoradiographs with an Ap- 
ple Color OneScanner (Apple Computer, Inc., Cupertino, CA) using the 
following software: Ofoto  (Light Source Computer Images, Inc., Lark- 
spur, CA), Adobe Photoshop (Adobe Systems, Inc., Mountainview, CA), 
and Canvas (Deneba Software, Miami, FL). The protein bands in the fig- 
ure have not been altered, enhanced or otherwise manipulated compared 
with the original autoradiograph. 
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Results 
Synaptogyrin Structure 
To obtain peptide sequence from synaptogyrin, we pooled 
synaptic vesicles from several preparations, stripped them 
of membrane-associated proteins with carbonate buffer at 
pH  11,  and  separated  the  proteins  by  two-dimensional 
electrophoresis. The position of synaptogyrin was identi- 
fied by immunoblotting. The corresponding spots were ex- 
cised  and  subjected  to  proteolytic cleavage, followed by 
peptide purification and microsequencing. 
Based  on the  peptide  sequences,  a  cDNA was cloned 
and sequenced. It contains an open reading frame predict- 
ing a protein of 234 amino acids with a molecular mass of 
25,683  D  (Fig.  1 a). The hydrophilicity plot (Fig.  1 b) re- 
vealed four hydrophobic stretches that fulfill the  criteria 
for transmembrane domains. Thus, the sequence predicts 
that the protein spans the membrane four times, with the 
NH2 and  COOH termini on the  cytoplasmic face of the 
vesicle (Fig. 1 c). This structure is reminiscent of synapto- 
physin.  Sequence  comparison revealed  that  the  proteins 
are different (Fig. 2 b), with identities being confined to a 
few small clusters. However, the cytoplasmic tails of syn- 
aptophysin and  synaptogyrin share  an  abundance  of the 
amino acids tyrosine, glutamine, glycine, proline, and as- 
partate/glutamate, comprising 74 and 57%, respectively, of 
Figure 1.  (a) Nucleotide  and amino acid sequence  of synaptogy- 
rin.  The putative transmembrane domains  are boxed, and the 
peptide sequences identified  by microsequencing  are underlined. 
(b)  Hydrophobicity plot of synaptogyrin,  plotted according  to 
Kyte and Doolittle (1982). Note the four hydrophobic stretches 
that represent putative transmembrane domains.  (c)  Model of 
the topology of synaptogyrin  in the vesicle membrane. P, phos- 
photyrosine.  Note that the number and location  of the phospho- 
tyrosine residues  are arbitrary and have not been determined. 
Both the NH2 and the COOH termini are predicted to  face the 
cytoplasm.  The positions  of the two peptides used to raise  do- 
main-specific antisera are included. 
all residues. It is possible that small clusters of these amino 
acids are responsible for the cross-reactivity of some of the 
monoclonal antibodies (clones C1 7.1  and 13.1)  described 
previously (Baumert et aL, 1990).  Unlike in synaptophysin, 
however, these amino acids are not organized in repetitive 
sequences. 
No consensus site for N-glycosylation was found in the 
synaptogyrin sequence, agreeing with our earlier observa- 
tions that the protein is not glycosylated. The first intrave- 
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Figure 3.  Comparison of na- 
tive  and recombinant synap- 
togyrin (expressed in COS-7 
cells),  demonstrating  identi- 
cal  migration  behavior  of 
both proteins in SDS-PAGE. 
The figure shows  an  immu- 
noblot of a brain fraction en- 
riched in synaptic vesicles  (left lane, see Huttner et al., 1983 for 
details)  and of extracts of COS-7 cells transfected with synapto- 
gyrin eDNA (middle  lane) and  of nontransfected  COS-7 cells 
(right lane). COS cell  homogenates were extracted with Triton 
X-100 and cleared by centrifugation before analysis (10 Ixg of pro- 
tein/lane,  detection by the enhanced chemiluminescence  method). 
For immunodetection, a  rabbit serum directed against p29 was 
used that was described earlier and that also reacts with synapto- 
physin due to synaptophysin contaminated antigen (Baumert et 
al., 1990). 
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Figure 2.  Amino acid sequence alignment of synaptogyrin with 
homologous proteins.  (a) Alignment with translated  cDNA se- 
quences from the database of expressed sequence tags (dbest) de- 
rived from human infant brain and spleen/liver  libraries  (Adams 
et al., 1993). For alignment, cDNA sequences were translated to 
the closest fit with synaptogyrin that included internal frameshifts 
in the nucleotide sequences. The composite sequence represents 
a synthesis  of five sequences (these sequence data are available 
from EMBL/Genbank/DDBJ accession numbers H20630, R61783, 
T26382, T77418, T96193,  and T96194)  that contain overlapping 
regions of high similarity  suggesting that they are representing 
the same protein. Alignment was performed using the program 
Lasergene (DNAStar, Inc., Madison, WI) using the clustal method 
with a PAM250 residue weight table. (b) Alignment of synapto- 
gyrin with rat synaptophysin. Alignment was performed using the 
same software and parameters as above. 
sicular loop contains two cysteine residues that may form 
an intramolecular disulfide bond. Interestingly, a disulfide 
bond is present within both of the intravesicular loops of 
synaptophysin (Johnston and SUdhof, 1990). It remains to 
be established  which of the tyrosines are phosphorylated 
since both cytoplasmic termini  of the protein  contain ty- 
rosine residues. 
With exception of the limited similarity to synaptophysin, 
no homologies to known proteins were found when vari- 
ous databases were searched for matches. Recently, how- 
ever,  a  database  was  made  public  that  contains  human 
eDNA  sequences  generated  by expressed  sequence  tags 
(Adams et al.,  1993).  Five eDNA sequences of this data- 
base showed significant homologies to synaptogyrin when 
translated  into  peptide  sequences  (Fig.  2  a).  Sequence 
comparison revealed that they might encode two different 
human  homologues  of synaptogyrin.  Thus,  synaptogyrin 
could represent  the first characterized  member of a  new 
protein  family.  Since  two  of  these  sequences  were  ob- 
tained from a liver-spleen library, it is possible that synap- 
togyrin isoforms  are expressed  in nonneuronal/nonendo- 
crine cells. 
To confirm that the cloned synaptogyrin cDNA encodes 
the entire p29 protein, we expressed the cDNA in COS-7 
cells. The product was analyzed by SDS-PAGE and immu- 
noblotting using a previously characterized anti-p29 rabbit 
serum (Baumert et al.,  1990).  As shown in Fig. 3, the se- 
rum reacted with a protein band that comigrates with na- 
tive synaptogyrin. 
Membrane Orientation of Synaptogyrin 
To map the membrane topology of synaptogyrin, we gen- 
erated a new set of antibodies that are specific for defined 
domains of the protein. First, two rabbit sera were gener- 
ated using immobilized synthetic peptides as antigens that 
correspond to domains in the first intravesicular loop (res- 
idues no. 59-71, syg-loop peptide) and the cytoplasmic tail 
(residues  no.  182-196, syg-tail peptide),  respectively.  Sec- 
ond, the  COOH-terminal  65  amino  acids, corresponding 
to the cytoplasmic tail of synaptogyrin (syg-tail), were ex- 
pressed  in Escherichia  coli as  a  glutathione-S-transferase 
fusion  protein.  The  purified  fusion  protein  was  used  to 
generate a rabbit serum and a mouse monoclonal antibody 
(hybridoma line CI 80.1, IgG2). In a  synaptosomal prepa- 
ration, all antibodies react with a major band of an appar- 
ent molecular mass of 29,000 D  comigrating with that rec- 
ognized by our previous anti-p29 antibody (Fig.  4).  With 
the exception  of some minor immunoreactive bands rec- 
ognized by the  syg-loop peptide  antibody,  no cross-reac- 
tivity with other proteins was observed demonstrating that 
the antibodies are specific for synaptogyrin. 
The Journal of Cell Biology, Volume 13 L, 1995  1804 Figure 4.  Characterization  of antibodies raised against synapto- 
gyrin fragments  and peptides  using immunoblot  analysis of iso- 
lated  nerve terminals  (12.5 Ixg of protein/lane).  (Left to  right) 
Anti-p29 serum, affinity-purified (Baumert et al., 1990); syg-tail 
peptide and syg-loop peptide: rabbit sera raised against synthetic 
peptides corresponding to sequences in the COOH-terminal tail 
and in the first intravesicular loop, respectively, of synaptogyrin 
(all diluted 1:500); syg-tail: rabbit serum raised against the bacte- 
rially expressed  COOH-terminal domain (dilution  1:20,000); C1 
80.1 IgG2  monoclonal antibody raised against the same antigen as 
syg-tail. 
A fraction enriched in synaptic vesicles was treated with 
the enzyme pronase for increasing amounts of time to pro- 
gressively digest exposed cytoplasmic domains of synapto- 
gyrin. The digests were then separated by SDS-PAGE and 
subsequently  analyzed  with  domain-specific  antibodies. 
As shown in Fig. 5 (left), protease treatment generated a 
fragment of synaptogyrin with an apparent mass of 18,000 
D  that was recognized by the loop peptide antibody but 
not by any of the tail-specific antibodies. Thus, the epitope 
recognized by the loop peptide antibody is protected from 
protease attack whereas the COOH terminus is not. This 
demonstrates that the COOH terminus is exposed on the 
cytoplasmic side of the vesicle whereas the epitope recog- 
nized by the loop peptide is facing the lumenal side, con- 
firming the topology suggested in Fig. 1 c. Prolonged incu- 
bation in pronase did not result in further degradation of 
the 18,000-D fragment. This is in contrast to the digestion 
pattern of synaptophysin (Fig. 5, middle and right). Here, a 
corresponding  loop  peptide  antibody  (Johnston  et  al., 
1989a) reveals the appearance of a larger fragment that is 
progressively degraded into a smaller fragment. The larger 
of them corresponds to a fragment devoid of both the NH  2 
and COOH termini but containing all transmembrane do- 
mains and both intravesicular loops whereas the smaller 
fragment represents the first two transmembrane domains 
and the first intravesicular loop (Johnston et al.,  1989a). 
Apparently, the small cytoplasmic loop between the sec- 
ond and the third transmembrane domains is more resis- 
tant to protease cleavage in synaptogyrin than in synap- 
tophysin.  This  may  be  explained  by  the  fact  that  in 
synaptogyrin the loop is predicted to be very short, com- 
prising  only 6-7  residues,  compared to 9-10 residues  in 
synaptophysin. That  only cytoplasmic domains  were  di- 
gested was confirmed by an analysis of synaptotagmin, a 
transmembrane protein with a different topology (Perin et 
al.,  1991).  Protease treatment generated a  fragment that 
was recognized by a monoclonal antibody specific for the 
NH2 terminus and that contains the transmembrane  and 
lumenal domains of the protein (Fig 5, far right). 
Expression of Synaptogyrin in Fibroblasts 
In  the  following  experiments,  we  transiently  expressed 
synaptogyrin in fibroblasts (CHO cells) in order to study 
its sorting in nonneuronal cells. Previous work has estab- 
lished  that  in  non-neuronal  cell  lines  synaptophysin  is 
sorted to an intracellular compartment that contains trans- 
fen-in receptors and is involved in the recycling of transferrin 
between the plasmalemma and early endosomes (Johnston 
et al., 1989b; Leube et al., 1989; Clift-O'Grady et al., 1990). 
In addition, the protein cellubrevin seems to be present in 
the same compartment (McMahon et al., 1993). Recent work 
has demonstrated that the expression pattern of other syn- 
aptic vesicle proteins is different from that of synaptophysin. 
This is most conspicuous for synaptotagmin that is found 
predominantly on the plasma membrane of transfected cells 
(Feany and Buckley, 1993; Feany et al.,  1993). For these 
reasons, we have compared the expression pattern of syn- 
aptogyrin  with  that  of  synaptophysin,  cellubrevin,  and 
transferrin. 
Synaptogyrin cDNA was transfected into CHO cells and 
its expression pattern was compared to that of cellubrevin 
using double labeling immunocytochemistry. As shown in 
Fig. 6 (top), the staining pattern of both proteins was virtu- 
ally identical as evidenced by double exposure. To further 
differentiate the localization of both proteins, double la- 
beled cells were also analyzed by confocal microscopy (Fig. 
6, second panel).  As evident from the color overlay, the 
majority of both proteins are colocalized. However, some 
differential localization was observed in the periphery of 
the cells (note green and red puncta in the color overlay). 
To compare the localization of synaptogyrin with that of 
synaptophysin, we transfected synaptogyrin into  a  CHO 
cell line that stably expresses synaptophysin and that has 
been  extensively  characterized  (Johnston  et  al.,  1989b; 
Cameron et al., 1991). Both conventional immunofluores- 
cence (not shown) and confocal microscopy (Fig. 6, third 
panel) indicated that synaptophysin and synaptogyrin dis- 
tributed in an almost identical pattern. Labeling resulted 
in the staining of small puncta that are scattered through- 
out the cytoplasm and concentrated in a  paranuclear re- 
gion, probably representing the location of an endosomal 
compartment involved in recycling of receptors. No signif- 
icant labeling of the plasma membrane was observed. Fur- 
thermore, we compared the labeling pattern of synaptogy- 
rin with that of internalized transferrin (Fig. 6, bottom). 
Again,  the confocal staining pattern was  similar but the 
color overlay showed  more  pronounced  differences be- 
tween the compartments containing the two proteins. Both 
proteins are colocalized in the paranuclear region but in 
the cell periphery many fine puncta positive for synapto- 
gyrin were devoid of transferrin, possibly due to the pres- 
ence of synaptogyrin in late endosomes and in membranes 
of the Golgi apparatus which do not participate in trans- 
ferrin recycling. Conversely, a minority of the larger puncta 
labeled for transferrin are negative for synaptogyrin, indi- 
Stenius  et al. Synaptogyrin,  a Synaptic Vesicle  Protein  1805 Figure 5.  Mapping of the transmembrane orientation of synaptogyrin using limited proteolysis of synaptic vesicles followed by immuno- 
blot analysis of the fragments with side-specific  antibodies. As reference, the partial digestion of synaptophysin and synaptotagmin, two 
integral membrane proteins of synaptic vesicles with an established orientation, was also monitored. The asterisks in the models indicate 
the position of the epitopes of the antibodies used for immunoblotting. Dotted lines in the models indicate regions expected to be de- 
graded by pronase. Note that only one fragment of synaptogyrin is generated the size of which indicates that the cytoplasmic loop be- 
tween transmembrane regions 2 and 3 is not cleaved. The size of all other fragments conform with the predictions of the models. 
cating some microheterogeneity between the two proteins. 
We  conclude  that  synaptogyrin  and  synaptophysin  are 
cosorted  to  the  same  recycling compartment.  This  com- 
partment  overlaps to a  large extent with cellubrevin and 
transferrin,  indicating  that  it  is  involved  in  constitutive 
membrane  traffic  between  the  plasma  membrane  and 
early endosomes. 
Discussion 
In the present study, we have characterized synaptogyrin, 
a  previously identified protein (p29)  of synaptic vesicles. 
Our structural analysis revealed that despite some similar- 
ities to synaptophysin, synaptogyrin is a novel protein with 
no  significant/sequence  homology  to  other  known  pro- 
teins. Homologies to cDNA sequences in the expressed se- 
quence  tag  database  indicate  that  it represents  the  first 
member of a new protein family. 
Synaptogyrin represents a  new addition to the growing 
list of proteins that contain four transmembrane domains, 
with both termini facing the cytoplasm, and that reside on 
intracellular  post-Golgi  compartments.  The  function  of 
these proteins is still unclear. The best known member of 
this group is synaptophysin (Jahn et al., 1985; Siidhof et al., 
1987).  It is the  most  abundant  representative of a  small 
protein family that  also includes synaptoporin (Knaus  et 
al.,  1992),  a  second  neuron-specific  isoform,  and  HL-5 
(also  referred  to  as  panthophysin;  Zhong  et  al.,  1992; 
Leube,  1994),  an isoform that  appears to be expressed in 
all tissues. Recently, it was shown that synaptophysin binds 
Figure 6.  Localization of synaptogyrin in CHO  cells by immunofluorescence that transiently express the protein. For synaptogyrin 
(syg), monoclonal antibody C1 80.1 was used. Note that not all cells express synaptogyrin. (Top) Comparison of the distribution of syn- 
aptogyrin (syg, green channel) and cellubrevin (ceb, red channel) using conventional immunofluorescence microscopy. Double labeling 
was performed using a polyclonal serum for cellubrevin. Double exposure shows that in the cells expressing synaptogyrin an almost 
identical staining pattern is obtained. (Second panel) Same as above (synaptogyrin, red channel, cellubrevin, green channel) except that 
the analysis was performed by confocal laser scanning microscopy. Note that in the color overlay (right) some differentiation between 
the two proteins is observed in the cell periphery. (Third panel) Comparison of the distribution of synaptogyrin (syg, red channel) and 
synaptophysin (syp, green channel, color overlay on the right), analyzed by confocal microscopy. For these experiments, a CHO cell line 
was used that stably expresses synaptophysin (Johnston et al., 1989b).  Note that the staining patterns are very similar in the cells ex- 
pressing both proteins (not all of the synaptophysin-containing cells express synaptogyrin). (Bottom) Double labeling of cells that were 
preincubated with iron-saturated transferrin for synaptogyrin (syg) and transferrin (tfr), analyzed by confocal microscopy. Note that the 
staining pattern for transferrin overlaps only partially with that of synaptogyrin, with the overlap being concentrated in a paranuclear 
spot, as expected for an endosomal location. Bars: (top) 9 tzm; (second panel) 10 txm; (third panel) 14 tzm; (bottom) 9 p.m. 
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exocytotic fusion  machine  (Calakos  and  Scheller,  1994; 
Edelmann et al., 1995; Washbourne et al., 1995).  Another 
vesicle protein of this category is SCAMP (secretory car- 
rier membrane protein), a membrane protein expressed in 
all tissues that probably has a similar topology but virtu- 
ally no homology to synaptophysin. It contains putative 
metal binding domains and regions with high potential for 
forming amphiphilic helices (Brand et al., 1991; Brand and 
Castle,  1993).  Peripherin/rds,  a  protein  confined to  the 
highly curved rim of the  discs in  the  outer segments  of 
photoreceptors (Molday et al., 1987; Connell and Molday, 
1990; Arikawa et al., 1992) has a similar topology and may 
be involved in stabilizing areas of high membrane curva- 
ture. Since there is no significant sequence homology be- 
tween these protein families it remains to be established 
whether these  proteins,  at least in part,  have analogous 
functional roles on their respective trafficking organelle, 
or whether they are functionally divergent. In addition to 
their membrane topology, they share a number of similari- 
ties that are intriguing: (a) all of these proteins have simi- 
lar molecular masses,  ranging from a  molecular mass of 
25,000 to 39,000 daltons; (b) with the exception of SCAMP, 
all proteins contain even numbers of cysteine residues in 
the lumenal domains suggesting that they form intramo- 
lecular disulfide bonds (demonstrated for synaptophysin; 
Johnston and Stidhof, 1990); (c) all proteins reside on highly 
curved organelles (most conspicuously for peripherin/rds) 
which led to the suggestion that they may confer stability 
to highly curved membrane regions; and (d) with the ex- 
ception of peripherin/rds,  all proteins have nonneuronal 
counterparts  suggesting  that  they are  basic  elements  of 
constitutive and regulated intracellular membrane traffic. 
Previously, we reported that synaptogyrin is selectively 
expressed in neurons and neuroendocrine cells (Baumert 
et al., 1990). We have reexamined the tissue-distribution 
of synaptogyrin using protocols that enrich for membrane 
proteins and thus allow the detection of very low protein 
levels (see e.g., McMahon et al., 1993). This was prompted 
by the  observation that  cellubrevin, a  nonneuronal  iso- 
form of synaptobrevin, is expressed at much lower levels 
in nonneuronal cells and was overlooked in our initial screen 
using a cross-reacting antibody. No detectable amounts of 
synaptogyrin protein were found in nonneuronal tissues, 
including liver and a variety of cell lines (unpublished ob- 
servations). Although our assay would have revealed syn- 
aptogyrin levels at least two orders of magnitude less than 
in the brain, we cannot exclude the presence of very low 
levels of synaptogyrin as the case is with synaptobrevin I 
and II (Ralston et al., 1994). In fact, synaptogyrin was also 
cloned from commercially available liver and thymus cDNA 
libraries  (unpublished  observations).  We  therefore per- 
formed Northern blots to determine the RNA expression 
levels in nonneuronal tissues. A  strongly expressed mes- 
sage of N4 kb was found in brain. Long exposures of the 
blot showed less abundant messages in other nonneuronal 
tissues (heart, spleen, lung, liver, skeletal muscle, kidney, 
and testes, unpublished observations). Therefore, synapto- 
gyrin expression on the RNA level is not restricted to neu- 
ronal tissues although the protein levels, if at all present, 
are very low. However, the existence of related cDNA se- 
quences in a human database derived from nonneuronal 
tissues suggests that synaptogyrin, like synaptophysin, has 
nonneuronal isoforms. Thus it is possible that synaptogy- 
rin represents a group of proteins that is present on traf- 
ficking organelles in all tissues. 
When  synaptogyrin  was  coexpressed  with  synapto- 
physin in fibroblasts, both proteins were distributed in a 
very similar  fashion.  Furthermore,  synaptogyrin  largely 
overlapped with endogenous cellubrevin and, albeit to a 
lesser extent, with endocytosed transferrin. Thus, the sort- 
ing of synaptogyrin is very similar to that of synaptophysin 
in nonneuronal as well as in neuronal cells. This agrees 
with our previous observation that synaptogyrin, like syn- 
aptophysin, has not been detected on large dense-core ves- 
icles  in  the  CNS  or chromaffin granules,  in  contrast  to 
other vesicle proteins such  as synaptobrevin and synap- 
totagmin  (Baumert  et  al.,  1990;  De  Camilli  and  Jahn, 
1990).  Thus it appears that both proteins share common 
sorting signals that direct them to an identical subset  of 
cellular organelles. 
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W. M. Keck Foundation Biotechnology Resource laboratory at Yale Uni- 
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